Management of Persistent Corneal Epithelial Defects with Human Amniotic Membrane-derived Dry Matrix
Sundas Maqsood,1,2 Kareem Elsawah,3 Navpreet Dhillon,1 Shady Soliman,3 Masara Laginaf,2 Vaishali Lodhia,2 Damian Lake,1 Samer Hamada,1 Mohamed Elalfy1– 3 1Corneo-Plastic Unit, Queen Victoria Hospital NHS, East Grinstead, UK; 2Eye Department, Maidstone and Turnbridge Wells Hospitals, Maidst...
Guardado en:
Autores principales: | Maqsood S, Elsawah K, Dhillon N, Soliman S, Laginaf M, Lodhia V, Lake D, Hamada S, Elalfy M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/929a404d26fa4cb9bbe9914f25ef5283 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Amniotic Membrane Transplantation in Ophthalmology: An Updated Perspective
por: Walkden A
Publicado: (2020) -
Amniotic membrane extract and eye drops: a review of literature and clinical application
por: Murri MS, et al.
Publicado: (2018) -
Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) study
por: McDonald MB, et al.
Publicado: (2018) -
Histopathological and Immunohistochemical Changes in the Amniotic Membrane of Gestational Diabetic Mothers
por: Togrul,Cihan, et al.
Publicado: (2017) -
Safety and efficacy of amniotic cytokine extract in the treatment of dry eye disease
por: Yeu E, et al.
Publicado: (2019)